Monday, June 15, 2026

Trump and Kim’s Surprise Meeting: What It Means for South-North Economic Stocks?

Trump may meet Kim Jong Un, boosting inter-Korean stocks despite low chances of actual meeting due to lack of communication.

Groundbreaking Single-Port Surgery: How a 23-Year-Old Woman Overcame Ovarian Cysts and Gallbladder Disease

A multidisciplinary team at Bundang CHA Women's Hospital performed groundbreaking robotic surgery, treating ovarian cysts and gallbladder disease simultaneously.

U.S. Targets $122.8B in Korean Exports as Section 301 Probe Puts Autos at Risk

The U.S. begins a Section 301 investigation into South Korea's overproduction in key export sectors, raising potential trade pressures.

Unlocking Opportunities: 2025 Bio GMP Training Program Launches at Daejeon University

HealthUnlocking Opportunities: 2025 Bio GMP Training Program Launches at Daejeon University
2025 Winter BioRG Practical Training Program in Biopharmaceutical GMP (Provided by Daejeon University) / News1
2025 Winter BioRG Practical Training Program in Biopharmaceutical GMP (Provided by Daejeon University) / News1

The RISE Project Group of Daejeon University held the opening ceremony for the 2025 Winter BioRG Practical Training Program in Biopharmaceutical GMP on Monday at the coworking space on the second floor of Daejeon Technopark’s D-Station, as announced on Tuesday.

The program is set to run for two weeks, from January 19 to 30. Industry professionals from Prime Healthcare, K-BIO Biopharmaceutical Production Center, Dong-A Pharmaceutical, and Janssen Korea, alongside professors from universities in the Daejeon area, will conduct hands-on training focused on biopharmaceutical production.

Each session will feature keynote speeches from local biotech company executives. On day one, Jo Gun-ho, Vice President of the Bio Healthcare Association, will deliver a lecture on the Current State of Daejeon’s Bio Healthcare Industry.

Subsequent guest speakers include Kim Jae-jun, Site Director at Merck BioProcessing Production Center; Yoo Seong-sik, Executive Director of the Central Vaccine Research Institute; Song Jong-am, Director at E&S Healthcare; Lee Sang-mok, Chief Executive Officer (CEO) of BioCure Farm; Park Young-woo, CEO of Y BioLogics; Kim Ui-jung, CEO of HLB Genex; and Kim Kyu-wan, Vice President of Alteogen.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles